Balance Sheets (USD $)	Mar. 31, 2013 Unaudited	Dec. 31, 2012 Audited
Current Assets
Cash and cash equivalents	$ 248,003	$ 95,069
Restricted cash and cash equivalents	1,950,000
Due from related party	236,774	134,654
Total Current Assets	2,434,777	229,724
Patents	7,000	7,000
Total Assets	2,441,777	236,724
Current Liabilities
Accounts payable	797,908	797,908
Accrued expenses	1,884,550	1,953,934
Derivative liability	2,345,621
Notes payable	773,279	773,279
Convertible notes payable, net	21,918
Total Current Liabilities	5,823,276	3,525,121
Stockholders (Deficit)
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 83,238,071 and 79,813,071 at March 31, 2013 and December 31, 2012, respectively)	83,238	79,813
Common stock subscribed but not yet issued (523,333 and 1,500,000 at March 31, 2013 and December 31, 2012, respectively)	523	1,500
Subscription receivable	0	(10,000)
Additional paid in capital	27,096,002	26,580,244
Common stock-warrants	132,831	203,237
Deferred compensation	(232,037)	(12,500)
Accumulated deficit	(30,462,057)	(30,130,692)
Total stockholders deficit	(3,381,498)	(3,288,398)
Total Liabilities and stockholders deficit	$ 2,441,777	$ 236,723